Yinuorui has been shortlisted as one of the first batch of “new species” enterprises in Hubei Province’s science and technology innovation program.

According to the announcement in the document "Implementation Plan for the Hubei Province Science and Technology Innovation 'New Species' Enterprise Cultivation Program" (E Ke Ji Tong [2021] No. 53), the list of enterprises included in the first batch of Hubei Province's science and technology innovation "new species" enterprises is hereby announced. Hubei Enoray Biopharmaceutical Co., Ltd. has been selected as a "Gazelle" enterprise under the Hubei Province Science and Technology Innovation New Species Program.

“Gazelle” enterprises are innovative companies that have entered a phase of rapid growth and are also “high-growth enterprises”—typical representatives of innovative development. Being selected as a “Gazelle” enterprise in Hubei Province’s science and technology innovation ecosystem marks YinoRui Company’s position at the forefront of scientific and technological innovation in Hubei Province. Under the leadership of Hongri Pharmaceutical, YinoRui Company will continue to drive technological innovation and enhance its core competitiveness.